Azienda Ospedaliera SS Antonio e Biagio
About Azienda Ospedaliera SS Antonio e Biagio
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Fondazione Italiana Linfomi ONLUS
20
Gruppo Italiano Trapianto di Midollo Osseo
7
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
6
Boehringer Ingelheim
6
International Extranodal Lymphoma Study Group (IELSG)
6
Celgene
5
Mario Negri Institute for Pharmacological Research
5
Astex Pharmaceuticals, Inc.
4
Associazione Qol-one
3
ETOP IBCSG Partners Foundation
3
European Organisation for Research and Treatment of Cancer - EORTC
3
Clinical Trials at Azienda Ospedaliera SS Antonio e Biagio
During the past decade, Azienda Ospedaliera SS Antonio e Biagio conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 21 clinical trials were completed, i.e. on
average, 35% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 12 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
1993-11-01
Unknown status
1,520
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
1995-08-01
Completed
392
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
1995-10-01
Unknown status
750
Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
2000-12-01
Unknown status
Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer
2001-09-01
Unknown status
700
Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)
2004-04-01
2007-05-01
Completed
5,745
MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation
2005-07-01
2015-12-01
Terminated
269
Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia
2004-10-01
2014-03-01
Completed
470
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Azienda Ospedaliera SS Antonio e Biagio" #1 sponsor was "Fondazione Italiana Linfomi ONLUS" with 20 trials, followed by "Gruppo Italiano Trapianto di Midollo Osseo" with 7 trials
sponsored, "Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria" with 6 trials sponsored, "Boehringer Ingelheim" with 6 trials sponsored and "International Extranodal Lymphoma Study Group (IELSG)"
with 6 trials sponsored. Other sponsors include 68 different institutions and
companies that sponsored additional 49 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera SS Antonio e Biagio"
#1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 6 trials as a collaborator, "PharmaMar" with 4 trials as a collaborator, "Breast International Group" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were
collaborators in the rest 44 trials.
Clinical Trials Conditions at Azienda Ospedaliera SS Antonio e Biagio
According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera SS Antonio e Biagio" are
"Myelodysplastic Syndromes" (9 trials), "Leukemia" (7 trials), "Acute Myeloid Leukemia" (5 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials) and "Lymphoma" (3 trials). Many other conditions were trialed in "Azienda Ospedaliera SS Antonio e Biagio" in a lesser frequency.
Clinical Trials Intervention Types at Azienda Ospedaliera SS Antonio e Biagio
Most popular intervention types in "Azienda Ospedaliera SS Antonio e Biagio" are "Drug" (92 trials), "Other" (13 trials), "Procedure" (9 trials), "Biological" (8 trials) and "Radiation" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Rituximab" (6 trials), "cyclophosphamide" (5 trials), "radiation therapy" (5 trials) and "Atezolizumab" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Azienda Ospedaliera SS Antonio e Biagio
The vast majority of trials in "Azienda Ospedaliera SS Antonio e Biagio" are
112 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Azienda Ospedaliera SS Antonio e Biagio
Currently, there are 40 active trials in "Azienda Ospedaliera SS Antonio e Biagio".
2 are not yet recruiting,
16 are recruiting,
21 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 59 completed trials in Azienda Ospedaliera SS Antonio e Biagio,
undefined suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Azienda Ospedaliera SS Antonio e Biagio, 3 "Phase 1"
clinical trials were conducted, 48 "Phase 2" clinical
trials and 46 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 4 trials that are defined as “Not Applicable".
Departments of Azienda Ospedaliera SS Antonio e Biagio
Azienda Ospedaliera SS Antonio e Biagio has several departments that took part in Clinical trials: "Ospedale Civile Ss. Antonio E Biagio Di Alessandria - Alessandria (Al) Oncologia Medica" - 3 trials
Departments List
Name
City
Trials